USPTO serial 77816858
HARNESS YOUR GENETIC ENERGY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GLASSER, CARYN
- Law office
- TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with HARNESS YOUR GENETIC ENERGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gabrielle A. Holley
GABRIELLE A. HOLLEY HOLLEY & MENKER, P.A.P.O. BOX 96SOLANA BEACH, CA 92075UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents, reagent kits, beads with attached biomolecules, buffers, and enzymes for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, genes, genomes, sequence variants and modifications, regulation, transcription, and expression, and for studying related associations in the fields of scientific, diagnostic and clinical research | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations; clinical diagnostic reagents, reagent kits, and beads with attached biomolecules; enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates, all the foregoing for use in clinical diagnostic analysis, genotyping, and sequencing | ACTIVE | — |
| 009 | Scientific instruments, namely nucleic acid sequencers, imaging devices, and analyzers; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, including arrays, flow cells, beads, bead sets; automated laboratory equipment and systems, including sample loaders and barcode readers; computer systems and software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research | ACTIVE | — |
| 010 | Clinical or medical diagnostic apparatus and instruments; arrays, beads, bead sets and flow cells; automated laboratory apparatus and systems; sample loaders and bar code readers for automated laboratory apparatus; computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in clinical diagnostic analysis, genotyping, and sequencing | ACTIVE | — |
| 040 | Custom synthesis of nucleotides, oligonucleotides, and other nucleic acids, and labeled derivatives thereof; and attachment to substrates; developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific, diagnostic and clinical research | ACTIVE | — |
| 042 | Scientific and technological services and research services relating thereto; laboratory services for preparation, detection, quantitation, and analysis of biological material, for genotyping, for diagnostic assays, and for carrying out nucleic acid sequencing reactions; consultancy, information and advisory services relating to the aforesaid services; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Illumina, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named HARNESS YOUR GENETIC ENERGY
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 19, 2010 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 19, 2010 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 7, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 3, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 3, 2009 | NWAP | NEW APPLICATION ENTERED | — |